Consulta los cursos, talleres, eventos próximos y anteriores sobre Dignidad Humana que sucederán en nuestros campus y regiones.
Conoce todas las actividades que tendrán lugar en los campus en el marco del 8M.
Check the courses and workshops available to you.
location_on MiTec > Success Factors > mi Aprendizaje > Oferta de desarrollo
calendar_month Siempre disponible
schedule Siempre disponible
Cursos de sensibilización en línea para todas las y los profesores y colaboradores.
location_on MiTec > Success Factors > mi Aprendizaje > Oferta de desarrollo
calendar_month Siempre disponible
schedule Siempre disponible
Cursos de capacitación en línea de actualización para las y los profesores y colaboradores.
location_on MiTec > Success Factors > mi Aprendizaje > Oferta de desarrollo
calendar_month Siempre disponible
schedule Siempre disponible
Curso para la sensibilizar sobre la importancia del uso del lenguaje inclusivo en la construcción de espacios seguros para todos los integrantes de la comunidad Tecnológico de Monterrey.
Conoce más información acerca de este curso.
location_on MiTec > Success Factors > mi Aprendizaje > Oferta de desarrollo
calendar_month Siempre disponible
schedule Siempre disponible
Curso sobre la inclusión, la no discriminación y la reducción de desigualdades de grupos históricamente discriminados.
Si requires una capacitación especializada para tu área o Departamento o si eres una experta o experto en temas de Dignidad humana y tienes cursos preparados comunícate con nosotros: centrodignidadhumana@itesm.mx
question_answer @DignidadHumanaC 
General:
email centrodignidadhumana@itesm.mx
Asesorías, dudas o reportes de violencia de género o discriminación:
email escuchandote@itesm.mx
Expertise
Genomic medicine in fibrotic diseases
Gene therapy
Dr. Armendáriz is recognized globally as one of the leading figures in the field of hepatology and as a pioneer in gene therapy. In addition to his contributions to Tecnológico de Monterrey, Dr. Armendáriz has collaborated for more than 25 years at the University of Guadalajara, where he became Full Professor "C", founder of the Department of Molecular Biology and Genomics, as well as founder and director of the Institute of Molecular Biology in Medicine at said university, one of the first programs in Mexico in what is now called Genomic Medicine. He has also been a visiting professor at the University of Florence, in Italy.
A Level III Emeritus Researcher of the Mexican National System of Researchers, much of Dr. Armendáriz's research has focused on the cellular and molecular basis of the treatment of liver cirrhosis and renal glomerulosclerosis.
As a result of his research, he has published more than 200 scientific articles, has presented more than 470 papers in national and international congresses, and has played leadership roles in the National Commission for the Human Genome, the Mexican Academy of Science, and the National Academy of Medicine (Mexico).
Among the most relevant recognitions of his career is the National Science Award "Mario Molina", obtained in 2023.
Dr. Armendáriz joined Tecnológico de Monterrey as a Distinguished Professor in Biomedical Sciences for the School of Medicine and Health Sciences.
Expertise
Medicina genómica en enfermedades fibróticas
Terapia génica
Dr. Armendáriz is recognized globally as one of the leading figures in the field of hepatology and as a pioneer in gene therapy. In addition to his contributions to Tecnológico de Monterrey, Dr. Armendáriz has collaborated for more than 25 years at the University of Guadalajara, where he became Full Professor "C", founder of the Department of Molecular Biology and Genomics, as well as founder and director of the Institute of Molecular Biology in Medicine at said university, one of the first programs in Mexico in what is now called Genomic Medicine. He has also been a visiting professor at the University of Florence, in Italy.
A Level III Emeritus Researcher of the Mexican National System of Researchers, much of Dr. Armendáriz's research has focused on the cellular and molecular basis of the treatment of liver cirrhosis and renal glomerulosclerosis.
As a result of his research, he has published more than 200 scientific articles, has presented more than 470 papers in national and international congresses, and has played leadership roles in the National Commission for the Human Genome, the Mexican Academy of Science, and the National Academy of Medicine (Mexico).
Among the most relevant recognitions of his career is the National Science Award "Mario Molina", obtained in 2023.
Dr. Armendáriz joined Tecnológico de Monterrey as a Distinguished Professor in Biomedical Sciences for the School of Medicine and Health Sciences.
Expertise
Immunotherapy
Stem cell transplantation
Dr. Alejandro Madrigal began his medical studies at the Universidad Nacional Autónoma de México (UNAM) and continued his training at some of the world’s top universities. He is currently a Professor of Hematology at UCL, a Faculty of Excellence professor at the Tecnológico de Monterrey, and a Professor Emeritus of the National System of Researchers in Mexico. He was an Honorary Affiliated Physician at the Royal Free Hospital (UK) and UCL Cancer Institute.
He founded and served as the first scientific director of the Anthony Nolan Research Institute in London, which supports people with blood cancer or disorders. He has trained numerous doctors and scientists and has developed multiple Registers for Unrelated Stem Cell Donors (USCD) and cord blood collection centers. His research focuses on how to improve immunotherapy and stem cell transplantation to make cancer cell therapy more accessible, particularly for minorities. He is a Fellow of the Academy of Medical Sciences and a member of the Royal College of Physicians (UK) and holds honorary memberships in the National Academy of Medicine (Mexico) and the Mexican Academy of Sciences.
He has secured multiple grants and has funded students and researchers. He has published over 570 papers, with more than 17,000 citations in journals like Nature and The Lancet. In 2023, he received the Carlos Slim Health Award for Lifetime Achievement in Research for his work on health issues in Latin America. He also holds four honorary doctorates and was appointed an Officer of the Most Excellent Order of the British Empire (OBE) by Queen Elizabeth II in 2022.
Alejandro Madrigal joined Tecnológico de Monterrey as a FEMSA Distinguished Professor in Hematology and Cellular Therapy for the School of Medicine and Health Sciences.
Madrigal, J. A., Chávez, M., & Mayani, H. (2022). Advanced Cell Therapy: Beyond the last Frontier in the Treatment of Cancer. A Historical Perspective Emphasizing the Work of Nobel Prize Laureates. Archives Of Medical Research, 53(8), 747-752. https://doi.org/10.1016/j.arcmed.2022.11.006
Ros-Soto, J., Snowden, J. A., Szydlo, R., Nicholson, E., Madrigal, A., Easdale, S., Potter, M., Ethell, M., & Anthias, C. (2022). Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics Matter. Transplantation And Cellular Therapy, 28(4), 183.e1-183.e8. https://doi.org/10.1016/j.jtct.2022.01.022
Petersdorf, E. W., Gooley, T., Volt, F., Kenzey, C., Madrigal, A., McKallor, C., Querol, S., Rafii, H., Rocha, V., Tamouza, R., Chabannon, C., Ruggeri, A., & Gluckman, É. (2020). Use of the HLA-B leader to optimize cord blood transplantation. Haematologica, 106(12), 3107-3114. https://doi.org/10.3324/haematol.2020.264424
Querol, S., Rubinstein, P., & Madrigal, A. (2021). The wider perspective: cord blood banks and their future prospects. British Journal Of Haematology, 195(4), 507-517. https://doi.org/10.1111/bjh.17468
Wynn, L. A., & Madrigal, A. (2021). Predictive analytics and cord blood banking: toward utilization-based unit selection. Cytotherapy, 23(7), 641-646. https://doi.org/10.1016/j.jcyt.2021.01.002
Expertise
Inmunoterapia
Trasplante de células madre
Dr. Alejandro Madrigal began his medical studies at the Universidad Nacional Autónoma de México (UNAM) and continued his training at some of the world’s top universities. He is currently a Professor of Hematology at UCL, a Faculty of Excellence professor at the Tecnológico de Monterrey, and a Professor Emeritus of the National System of Researchers in Mexico. He was an Honorary Affiliated Physician at the Royal Free Hospital (UK) and UCL Cancer Institute.
He founded and served as the first scientific director of the Anthony Nolan Research Institute in London, which supports people with blood cancer or disorders. He has trained numerous doctors and scientists and has developed multiple Registers for Unrelated Stem Cell Donors (USCD) and cord blood collection centers. His research focuses on how to improve immunotherapy and stem cell transplantation to make cancer cell therapy more accessible, particularly for minorities. He is a Fellow of the Academy of Medical Sciences and a member of the Royal College of Physicians (UK) and holds honorary memberships in the National Academy of Medicine (Mexico) and the Mexican Academy of Sciences.
He has secured multiple grants and has funded students and researchers. He has published over 570 papers, with more than 17,000 citations in journals like Nature and The Lancet. In 2023, he received the Carlos Slim Health Award for Lifetime Achievement in Research for his work on health issues in Latin America. He also holds four honorary doctorates and was appointed an Officer of the Most Excellent Order of the British Empire (OBE) by Queen Elizabeth II in 2022.
Alejandro Madrigal joined Tecnológico de Monterrey as a FEMSA Distinguished Professor in Hematology and Cellular Therapy for the School of Medicine and Health Sciences.
Madrigal, J. A., Chávez, M., & Mayani, H. (2022). Advanced Cell Therapy: Beyond the last Frontier in the Treatment of Cancer. A Historical Perspective Emphasizing the Work of Nobel Prize Laureates. Archives Of Medical Research, 53(8), 747-752. https://doi.org/10.1016/j.arcmed.2022.11.006
Ros-Soto, J., Snowden, J. A., Szydlo, R., Nicholson, E., Madrigal, A., Easdale, S., Potter, M., Ethell, M., & Anthias, C. (2022). Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics Matter. Transplantation And Cellular Therapy, 28(4), 183.e1-183.e8. https://doi.org/10.1016/j.jtct.2022.01.022
Petersdorf, E. W., Gooley, T., Volt, F., Kenzey, C., Madrigal, A., McKallor, C., Querol, S., Rafii, H., Rocha, V., Tamouza, R., Chabannon, C., Ruggeri, A., & Gluckman, É. (2020). Use of the HLA-B leader to optimize cord blood transplantation. Haematologica, 106(12), 3107-3114. https://doi.org/10.3324/haematol.2020.264424
Querol, S., Rubinstein, P., & Madrigal, A. (2021). The wider perspective: cord blood banks and their future prospects. British Journal Of Haematology, 195(4), 507-517. https://doi.org/10.1111/bjh.17468
Wynn, L. A., & Madrigal, A. (2021). Predictive analytics and cord blood banking: toward utilization-based unit selection. Cytotherapy, 23(7), 641-646. https://doi.org/10.1016/j.jcyt.2021.01.002
Expertise
Digital animation
Storytelling
Storyboards
Under the premise that “animation is the greatest form of visual storytelling,” Travis Blaise co-founded the SketchToAnimate initiative, where he is also the director of the upcoming ARC series and instructor. Through that platform, he has created workshops, tutorials, and online classes covering character design, animation, storyboarding, and building an animation portfolio.
In 2008, he was an adjunct professor for an experimental 2D animation class at CalArts (California, U.S.). From 2017 to 2021, he was a mentor, instructor, and adjunct professor at DigiPen Studios, training students in animation and storyboarding. His latest work was as a storyboard artist on the movie Mufasa (2024).
With over 34 years of experience, Travis Blaise has participated in a wide range of movies and TV shows throughout his career in storyboard artistry, including Disenchantment (2021), Big Mouth (2017), Disney’s Penn Zero (2014), and his animation work with Brother Bear (2003), Lilo & Stitch (2002), Mulan (1998), and The Lion King (1994). He worked for Disney from 1990 to 2004, where he served as an in-between artist and animator in films and video games. After his time at Disney, he worked for studios such as Cartoon Network, The Walt Disney Company, Nickelodeon Animation Studio, Netflix, and Warner Bros.
He is a global lecturer and speaker on the production of digital art, animation, and storytelling projects at CalArts, DigiPen, Toon Boom, Wacom, Disney, the Orlando Museum of Art, the Annecy Festival, and the Bangkok Comic Con, to name a few.
Travis Blaised joined Tecnológico de Monterrey as a Distinguished Visiting Professor in Animation and Storytelling for the School of Architecture, Art and Design.
Expertise
Animación digital
Narración (storytelling)
Guiones gráficos
Under the premise that “animation is the greatest form of visual storytelling,” Travis Blaise co-founded the SketchToAnimate initiative, where he is also the director of the upcoming ARC series and instructor. Through that platform, he has created workshops, tutorials, and online classes covering character design, animation, storyboarding, and building an animation portfolio.
In 2008, he was an adjunct professor for an experimental 2D animation class at CalArts (California, U.S.). From 2017 to 2021, he was a mentor, instructor, and adjunct professor at DigiPen Studios, training students in animation and storyboarding. His latest work was as a storyboard artist on the movie Mufasa (2024).
With over 34 years of experience, Travis Blaise has participated in a wide range of movies and TV shows throughout his career in storyboard artistry, including Disenchantment (2021), Big Mouth (2017), Disney’s Penn Zero (2014), and his animation work with Brother Bear (2003), Lilo & Stitch (2002), Mulan (1998), and The Lion King (1994). He worked for Disney from 1990 to 2004, where he served as an in-between artist and animator in films and video games. After his time at Disney, he worked for studios such as Cartoon Network, The Walt Disney Company, Nickelodeon Animation Studio, Netflix, and Warner Bros.
He is a global lecturer and speaker on the production of digital art, animation, and storytelling projects at CalArts, DigiPen, Toon Boom, Wacom, Disney, the Orlando Museum of Art, the Annecy Festival, and the Bangkok Comic Con, to name a few.
Travis Blaised joined Tecnológico de Monterrey as a Distinguished Visiting Professor in Animation and Storytelling for the School of Architecture, Art and Design.
